Potassium Chloride and Glucose Intravenous Infusion
Potassium Chloride and Sodium Chloride Intravenous Infusion
Potassium Chloride Concentrate (Sterile)
Potassium Chloride, Sodium Chloride and Glucose Intravenous Infusion
Bicarbonate and lactate
Compound Sodium Lactate Intravenous Infusion (Known as hartmanns solution)
Sodium Bicarbonate (injection)
Plasma and plasma substitutes
Human Albumin Solution
Section Title (top level)
Section Title (sub level)
First Choice item
Non Formulary section
Display tracking information
Link to adult BNF
Link to children's BNF
Link to SPCs
Scottish Medicines Consortium
High Cost Medicine
Cancer Drugs Fund
Traffic Light Status Information
Drugs that may be initiated, stabilised and maintained by primary, secondary or tertiary care
Secondary and tertiary care prescribing may be continued by primary care.
[this does not indicate first/second line choice]
Items used by the Hospital but would not normally be continued into primary care.
Primary care prescribers can change to GREEN first or second.
Initiation of drugs by primary care following written advice from secondary/ tertiary care advice.
Drugs that may be continued in primary care following initiation and stabilisation in secondary/tertiary care
Items requiring a shared care agreement.
These items should be initiated and stabilised by secondary or tertiary care.
The GP should only be asked to take over prescribing through a formal shared care agreement.
Secondary care will be expected to continue prescribing until the agreement is made.
Hospital/ Trust ONLY.
These are items the secondary and tertiary care are responsible for prescribing and will need to continue to prescribe for long term maintenance.
These items will NOT be prescribed in primary care. But primary care should be informed the patient is receiving these items.
This will include NHSE funded items requiring repatriation.
Items covered by NHSE ‘Should not prescribe in primary care list’ – See CCG policy on Drugs of limited clinical value
Grey List: Items covered by NHSE ‘Should not prescribe in primary care list’ that are not to be routinely prescribed but may be suitable in a defined population –
See CCG policy on Drugs of limited clinical value